A popular blood pressure medication is undergoing a recall due to concerns of potential contamination with another drug.
Glenmark Pharmaceuticals Inc in the US is recalling over 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets, known as Ziac. The recall was initiated after a notice from the Food and Drug Administration indicated possible cross-contamination with other substances.
These tablets are commonly prescribed for managing high blood pressure, or hypertension, by blocking beta-1 receptors in the heart to regulate its rhythm, as per information from WebMD.
According to the recall notice, testing revealed the presence of ezetimibe, a medication used to address high cholesterol. The recall, categorized as Class III, indicates that the likelihood of adverse health effects from using or being exposed to the product is low, according to the FDA.
The impacted pills are available in 2.5mg and 6.25mg doses. Specific affected packages include 30-count bottles NDC-68462-878-30, 100-count bottles NDC-68462-878-01, and 500-count bottles NDC-68462-878-05, as outlined in the recall notice.
The affected lot numbers have expiration dates ranging from November 2025 to May 2026, totaling 11,136 bottles subject to the recall. Guidance on actions for patients with affected medication has not been provided by the FDA at this time.
